RESEARCH & DIAGNOSTIC ANTIBODIES – Trademark Portfolio
Entity Type: 03
RESEARCH & DIAGNOSTIC ANTIBODIES holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include R&D AB. The owner is based in Las Vegas, NV.
9030 West Sahara Ave. #403
Las Vegas, NV 89117
Showing of trademarks Trademarks
Trademark Classifications
RESEARCH & DIAGNOSTIC ANTIBODIES's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does RESEARCH & DIAGNOSTIC ANTIBODIES have?
RESEARCH & DIAGNOSTIC ANTIBODIES has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 5 cancelled.
What trademark classes does RESEARCH & DIAGNOSTIC ANTIBODIES file in?
RESEARCH & DIAGNOSTIC ANTIBODIES files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are RESEARCH & DIAGNOSTIC ANTIBODIES's most well-known trademarks?
RESEARCH & DIAGNOSTIC ANTIBODIES's registered trademark portfolio includes well-known marks such as R&D AB. These are among 1 currently registered trademark in the portfolio.
What is RESEARCH & DIAGNOSTIC ANTIBODIES's trademark registration success rate?
RESEARCH & DIAGNOSTIC ANTIBODIES has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.